Advertisement Sinclair Pharma oral lesion spray launched in US - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Sinclair Pharma oral lesion spray launched in US

UK-based Sinclair Pharma has reported that Aloclair, an oral lesion relief spray, has been launched in the US under the brand name Ameseal, by OMNI Preventive Care, a 3M ESPE company.

According to the company, Ameseal is a convenient, portable pocket pack that provides long lasting pain relief from mouth ulcers, irritations or sores. The spray on application on the ulcer forms a protective barrier and prevents painful stimulation by chewing, speaking, eating or drinking. OMNI has exclusive rights to promote Ameseal spray in the US market.

Kevin Thomas, general manager of OMNI Preventive Care, said: “Ameseal will be a great addition to the preventive line of products that we offer to dental professionals. The oral lesion relief category is an important part of our portfolio and we look forward to the benefits that Ameseal can bring to the American market.”